Gene: DEPDC4
Official Full Name: DEP domain containing 4provided by HGNC
Gene Summary: Predicted to be involved in intracellular signal transduction. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30318 | DEPDC4 Knockout cell line (HeLa) | Human | DEPDC4 | 1:3~1:6 | Negative | Online Inquiry |
KO30319 | DEPDC4 Knockout cell line (HCT 116) | Human | DEPDC4 | 1:2~1:4 | Negative | Online Inquiry |
KO30320 | DEPDC4 Knockout cell line (HEK293) | Human | DEPDC4 | 1:3~1:6 | Negative | Online Inquiry |
KO30321 | DEPDC4 Knockout cell line (A549) | Human | DEPDC4 | 1:3~1:4 | Negative | Online Inquiry |
DEPDC4 Gene Knockout Cell Lines represent a sophisticated tool in molecular biology, designed specifically to facilitate the functional analysis of the DEPDC4 gene, known for its role in regulating cellular processes such as proliferation, differentiation, and survival. Utilizing advanced CRISPR-Cas9 technology, these cell lines allow researchers to induce targeted deletions of the DEPDC4 gene, enabling the study of its impact on various signaling pathways and cellular phenotypes.
The core mechanism behind the DEPDC4 Gene Knockout Cell Lines involves site-specific genome editing, which leads to the production of knockout cells that lack the DEPDC4 protein. This allows for a direct evaluation of the gene's function and interactions in cellular contexts, thus providing insights that are critical for elucidating its roles in diseases, particularly cancer. When utilized in research, these cell lines serve as a vital component in investigating mechanisms of neoplasia, drug resistance, and gene regulation.
From a scientific perspective, the DEPDC4 Gene Knockout Cell Lines have significant applications in both basic and translational research. They are instrumental in elucidating gene function, validating drug targets, and discovering novel therapeutic strategies. The ability to model diseases more accurately owing to the specific alterations in gene expression makes these cell lines an invaluable asset in drug development and biomarker discovery.
What sets our DEPDC4 Gene Knockout Cell Lines apart from alternatives is not only their high efficiency in gene editing but also their robustness in diverse experimental conditions, ensuring reproducibility and reliability in research outcomes. Our product is backed by comprehensive validation and characterization data that ensure that researchers spend less time troubleshooting and more time focusing on their discoveries.
Ultimately, the DEPDC4 Gene Knockout Cell Lines embody a commitment to advancing life sciences research, and our company prides itself on its extensive expertise in providing high-quality, customizable biological products that meet the evolving needs of the research community. We believe that our innovative solutions will empower researchers and clinicians alike to achieve groundbreaking advancements in their fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.